Cerebral Palsy Treatment Market Insights 2030:
The global cerebral palsy treatment market size was valued at $3166.82 million in 2020, and is projected to reach $4,365.01 million by 2030, registering a CAGR of 3.3% from 2021 to 2030. Cerebral palsy is a combination of different disorders that effect a person’s ability to maintain posture caused majorly, owing to abnormalities in the brain. Apart from movement and posture, a person suffering from cerebral palsy may witness problems with hearing, speech, changes in spine such as scoliosis or joint problems including contractures. Four major types of cerebral palsy are prevalent across the globe.
Spastic cerebral palsy effects muscle stiffness resulting in awkward movements. The stiffness occurs in legs and arms. This leads to difficulty in walking due to tight leg muscles. Vice versa in dyskinetic cerebral palsy, people have problems with controlling hand and arm movements, making it difficult to walk and do stuff. Furthermore, ataxic cerebral palsy leads to balancing issues, resulting in unsteady movements. Early symptoms of cerebral palsy include stiffness and loopside crawling.
Cerebral palsy diagnosis involves developmental monitoring, which involves tracking patient’s development over time, developmental screening in which a short test is given to figure out whether the patient suffers from any developmental delays such as movement or motor skill delays. In case the doctor finds discrepancies, referrals are made pertaining to further evaluations. Further treatment involves intervention services, which include specialized government–NGO-collaborated plans. Rise in incidents of cerebral palsy and related chronic diseases, coupled with rising awareness on advanced therapeutics for quick treatment is anticipated to drive cerebral palsy treatment market growth in coming years.
Increase in healthcare expenditure sourced by both government treasuries and private sector investments, coupled with growing shift toward new age technologically integrated healthcare mechanisms are further expected to boost the market growth for cerebral palsy treatment medications. This trend is more likely to be witnessed in regions with growing purchasing power parity. Rising demand for more research and development investments pertaining to pharmaceutical industry is anticipated to further propel the market growth for cerebral palsy treatment.
Acute side effects associated with administration of drugs pertaining to cerebral palsy may hamper the market growth. In addition, conception of nonsurgical treatments such as physiotherapy and rehabilitation centers, coupled with decline in focus from surgical procedures in industrialized regions hamper market penetration of cerebral palsy treatment surgeries.
Impact Of Covid-19 On Cerebral Palsy Treatment Market (Pre And Post Analysis)
The COVID-19 outbreak is anticipated to have a negative impact on growth of the global cerebral palsy treatment market. The COVID-19 pandemic has stressed healthcare system in the world and increased the need to identify the strain of new coronavirus. During the lockdown, patients faced an interruption of their ongoing treatment. Although community-dwelling individuals with disability were given special permission to go out, physical therapy and rehabilitation services were disrupted. Patients suffering from cerebral palsy had to switch to tele-medicine during the lockdown as they couldn’t visit the hospitals.
Cerebral Palsy Treatment Market Segmentation
The report segments the cerebral palsy treatment market based on drug type, disease type, distribution channel, and region. Based on drug type, it is classified into anticholinergics, anticonvulsants, antidepressants, and others.
By Drug Type
Anticonvulsants segment dominated the market in 2020 and would continue to maintain the lead over the forecast period.
Based on disease type, it is classified into spastic cerebral palsy, dyskinetic cerebral palsy, ataxic cerebral palsy, and mixed cerebral palsy. Based on distribution channel, the market is divided into hospital pharmacies, retail stores and pharmacies, and online providers. Based on the region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment review
By drug type, the anticonvulsants segment currently dominates the global cerebral palsy treatment market and is expected to continue during the forecast period owing to increasing prevalence rate of cerebral palsy, and rise in the approval of anticonvulsant drugs from the U.S. Food and Drug Administration (FDA). By disease type, the spastic cerebral palsy segment dominated the global cerebral palsy treatment market in 2020, as around 80% of the total cerebral palsy patients are suffering from spastic cerebral palsy.
By Disease Type
Spastic Cerebral Palsy segment held a dominant position in 2020.
By distribution channel, the retail stores and pharmacies segment dominated the global cerebral palsy treatment market in 2020 and is anticipated to grow owing to recent upgrades in the pharmaceutical sector, increase in expenses on the health & medicines, easy access to pharmaceuticals for the general population, rise in awareness for cerebral palsy disorders thereby encouraging the treatments, and boost in the health insurance penetration.
By Distribution Channel
Retail Stores & Pharmacy segment held a dominant position in 2020.
Region Segment Review
Region wise, North America dominated the cerebral palsy treatment market in 2020, owing to significant rise in investments as well as partnerships and collaborations. However, Asia-Pacific is expected to witness considerable market growth during the forecast period, due to increase in number of initiatives along with enhanced investments for the overall R&D of cerebral palsy treatment. Moreover, India and China are expected to grow at high CAGR in the Asia-Pacific medical device outsourcing market.
The key players in this market have adopted product launch as one of their key developmental strategies. The major companies profiled in this report include Merz Pharmaceuticals, LLC., Pfizer Inc., Teva Pharmaceuticals, Bayer AG, Johnson & Johnson, GlaxoSmithKline plc., Novartis, AbbVie Inc., Par Pharmaceutical, Allergan plc., Lannett Company, Inc.
By Region
Asia- Pacific region would exhibit the fastest CAGR of 4.5% during the forecast period.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the global cerebral palsy treatment market along with the current trends and future estimations to explain the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the cerebral palsy treatment market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing cerebral palsy treatment market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products of cerebral palsy treatment used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the cerebral palsy treatment market.
Cerebral Palsy Treatment Market Report Highlights
| Aspects | Details |
 By Drug Type |
|
 By Disease Type |
|
 By Distribution Channel |
|
 By Region |
|
 By Key Market Players |
|
Analyst Review
According to the Analyst’s perspective, the utilization of cerebral palsy treatment is projected to witness a significant rise with growth in number of cerebral palsy patients across the globe. It is expected to witness high demand for the medications, owing to rise in cases of cerebral palsy patients. The cerebral palsy treatments are getting better and more advanced than its predecessors, owing to rising activities in the R&D segments of the key players. The cerebral palsy treatment market has gained momentum in the research, innovation, and development sectors, owing to surge in the number of cerebral palsy across the globe, significant technological advancements, and surge in the product launches, business expansions & FDA approvals among manufacturing companies and other organizations. In addition, rise in awareness regarding the cerebral palsy treatments and its advantages supplement the market growth. North America is expected to present lucrative growth opportunities to the key players in the industry.
The demand of chronic kidney diseases has increased significantly due to rising cases of patients. Moreover, the introduction of novel drugs and improvements in the existing products are propelling the market growth. However, side effects associated with the drugs are proving a big challenge for the global market. According to the Analyst, the utilization of cerebral palsy treatment is higher in hospitals as compared to other distribution channels. In addition, cerebral palsy medication manufacturers, developers, and distributors have focused on expanding their presence in emerging economies to expand their market outreach.
Cerebral palsy is a group of disorders that affect a person’s ability to move and maintain balance and posture.
The total market value of Global Cerebral Palsy Treatment Market is $3,166.82 million in 2020.
The forcast period for Global Cerebral Palsy Treatment Market is 2021 to 2030.
The market value of Global Cerebral Palsy Treatment Market in 2030 is $4,365.01 million.
Merz Pharmaceuticals, LLC., Pfizer, Inc., Teva Pharmaceuticals, Bayer AG, and Johnson and Johnson held a high market postion owing to the strong geographical foothold in different regions.
Spastic Cerebral Palsy Treatment segment dominates the global market, as around 80% of the total cerebral palsy patients are suffering from spastic cerebral palsy.
The major factor for the growth of Global Cerebral Palsy Treatment Market are increase in incidences of cerebral palsy and rise in the investment by key players.
Owing to rise in the geriatic population in the market. Furthermore, initiatives by governments for regulatory approvals.
The base year is 2020 in Global Cerebral Palsy Treatment Market.
Cerebral Palsy treatments are used for the treatments of cerebral palsy disorder.
Loading Table Of Content...
